{"DataElement":{"publicId":"8081471","version":"1","preferredName":"Biospecimen Events Domain Reported Event Term Sponsor Defined Type","preferredDefinition":"Terminology assigned by the sponsor to the codelist associated with the biospecimen event observation.","longName":"BETERM_SPD","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"8075213","version":"1","preferredName":"Biospecimen Events Domain Reported Event Term","preferredDefinition":"An events domain that documents biospecimen collection and storage information._The collected name for an event observation.","longName":"6983057v1.0:6922044v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6983057","version":"1","preferredName":"Biospecimen Events Domain","preferredDefinition":"An events domain that documents biospecimen collection and storage information.","longName":"C111138","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biospecimen Events Domain","conceptCode":"C111138","definition":"An events domain that documents biospecimen collection and storage information.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"94E41BF3-F82C-2CB7-E053-F662850A84C2","latestVersionIndicator":"Yes","beginDate":"2019-10-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-10-14","modifiedBy":"ONEDATA","dateModified":"2019-10-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6922044","version":"1","preferredName":"Reported Term","preferredDefinition":"The literal identifier assigned to an event.","longName":"C82571","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reported Event Term","conceptCode":"C82571","definition":"The collected name for an event observation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"92380E2F-2AE2-4CD6-E053-F662850A5FE6","latestVersionIndicator":"Yes","beginDate":"2019-09-10","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-09-10","modifiedBy":"ONEDATA","dateModified":"2019-09-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9CCD0A5-03D8-1DB2-E053-4EBD850AEA89","latestVersionIndicator":"Yes","beginDate":"2022-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-09","modifiedBy":"TAYLORT","dateModified":"2022-04-18","changeDescription":"Leidos Biospecimen Roadmap; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"8075336","version":"1","preferredName":"Reported Event Term Clinical Study Sponsor Defined Type","preferredDefinition":"The collected name for an event observation._An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]._Clearly characterized or delimited._Something distinguishable as an identifiable class based on common qualities.","longName":"TERM_SPD","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"BIOMARKER ASSAY","valueDescription":"Biomarker Assay","ValueMeaning":{"publicId":"8075337","version":"1","preferredName":"Biomarker Assay","longName":"8075337","preferredDefinition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.: A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Biomarker","conceptCode":"C16342","definition":"A characteristic that can be objectively measured and serves as an indicator for normal biologic processes, pathogenic processes, state of health or disease, the risk for disease development and/or prognosis, or responsiveness to a particular therapeutic intervention.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Assay","conceptCode":"C60819","definition":"A qualitative or quantitative analysis performed to determine the amount of a particular constituent in a sample or the biological or pharmacological properties of a drug.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9CF15E2-84BB-0AB1-E053-4EBD850A103F","latestVersionIndicator":"Yes","beginDate":"2022-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-09","modifiedBy":"ONEDATA","dateModified":"2022-03-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9CF15E2-84D6-0AB1-E053-4EBD850A103F","beginDate":"2022-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-09","modifiedBy":"ONEDATA","dateModified":"2022-03-09","deletedIndicator":"No"},{"value":"PRE-ANALYTIC TEST","valueDescription":"Pre-Analysis Test","ValueMeaning":{"publicId":"8004174","version":"1","preferredName":"Pre-Analysis Test","longName":"8004174","preferredDefinition":"Earlier in time or order.: Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.: A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Prior","conceptCode":"C25629","definition":"Earlier in time or order.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Analysis","conceptCode":"C25391","definition":"Examination and interpretation; the process of identifying an issue to be understood and addressed, modelling the issue, investigating the model results, interpreting the results, and possibly making a recommendation. The concept also refers to the examination and study of a whole in terms of the parts composing it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Test","conceptCode":"C47891","definition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5DCA4B7-9044-7777-E053-4EBD850A539F","latestVersionIndicator":"Yes","beginDate":"2022-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-01-18","modifiedBy":"TAYLORT","dateModified":"2022-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9CF15E2-84E0-0AB1-E053-4EBD850A103F","beginDate":"2022-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-09","modifiedBy":"ONEDATA","dateModified":"2022-03-09","deletedIndicator":"No"},{"value":"INITIAL SHIPMENT","valueDescription":"Initial Shipment","ValueMeaning":{"publicId":"8004173","version":"1","preferredName":"Initial Shipment","longName":"8004173","preferredDefinition":"Preceding all others in time or space or degree.: The act or business of transporting goods.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"First","conceptCode":"C25509","definition":"Preceding all others in time or space or degree.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Shipping","conceptCode":"C40353","definition":"The act or business of transporting goods.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5E0DCC7-DE8E-2A16-E053-4EBD850A9EE2","latestVersionIndicator":"Yes","beginDate":"2022-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-01-18","modifiedBy":"TAYLORT","dateModified":"2022-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9CF15E2-84EA-0AB1-E053-4EBD850A103F","beginDate":"2022-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-09","modifiedBy":"ONEDATA","dateModified":"2022-03-09","deletedIndicator":"No"},{"value":"DOWNSTREAM SHIPMENT","valueDescription":"Downstream Shipping","ValueMeaning":{"publicId":"8004183","version":"1","preferredName":"Downstream Shipping","longName":"8004183","preferredDefinition":"The process of shipping something from one facility to another, usually to a customer or end user, or to a more specialized facility.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Downstream Shipping","conceptCode":"C185233","definition":"The process of shipping something from one facility to another, usually to a customer or end user, or to a more specialized facility.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5E23595-4FF4-2540-E053-4EBD850A035A","latestVersionIndicator":"Yes","beginDate":"2022-01-18","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-01-18","modifiedBy":"ONEDATA","dateModified":"2022-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"D9CF15E2-84F4-0AB1-E053-4EBD850A103F","beginDate":"2022-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-09","modifiedBy":"ONEDATA","dateModified":"2022-03-09","deletedIndicator":"No"},{"value":"RETURN TO BIOBANK","valueDescription":"Return to Biobank","ValueMeaning":{"publicId":"8083715","version":"1","preferredName":"Return to Biobank","longName":"8083715","preferredDefinition":"An indication that a sample should be returned to its biobank.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Return to Biobank","conceptCode":"C186295","definition":"An indication that a sample should be returned to its biobank.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"DA32279E-730F-5875-E053-4EBD850A495D","latestVersionIndicator":"Yes","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DA32279E-732A-5875-E053-4EBD850A495D","beginDate":"2022-03-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-14","modifiedBy":"ONEDATA","dateModified":"2022-03-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"8081474","version":"1","preferredName":"Reported Event Term Clinical Study Sponsor Defined Type","preferredDefinition":"The collected name for an event observation.:An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]:Clearly characterized or delimited.:Something distinguishable as an identifiable class based on common qualities.","longName":"C82571:C70793:C165683:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reported Event Term","conceptCode":"C82571","definition":"The collected name for an event observation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Sponsor","conceptCode":"C70793","definition":"An entity such as an individual, company, institution, group, or organization which takes responsibility for the initiation, management, and/or financing of a clinical study. The sponsor does not actually conduct the investigation unless the sponsor is a sponsor-investigator. A person other than an individual (e.g., corporation or agency) that uses one or more of its own employees to conduct research it has initiated is considered to be a sponsor, and the employees are considered to be investigators. [21 CFR P.50.3(k)] [21 CFR P.50.102(j)] [21 CFR P.312.3]","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Defined","conceptCode":"C165683","definition":"Clearly characterized or delimited.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F2C79A-B5FB-760D-E053-4EBD850A5A82","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-11","modifiedBy":"ONEDATA","dateModified":"2022-03-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9CF15E2-84A3-0AB1-E053-4EBD850A103F","latestVersionIndicator":"Yes","beginDate":"2022-03-09","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-09","modifiedBy":"TAYLORT","dateModified":"2022-04-18","changeDescription":"Leidos Biospecimen Roadmap; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7668442","version":"1","longName":"CDISC Content","context":"Theradex","ClassificationSchemeItems":[{"publicId":"7668399","version":"1","longName":"CDASH Compliant","context":"Theradex"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Theradex - 1","type":"Alternate Question Text","description":"Event","url":null,"context":"Theradex"},{"name":"Biospecimen Event Term","type":"Preferred Question Text","description":"Biospecimen Event Term","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D9F1C569-D861-6B39-E053-4EBD850A88B6","latestVersionIndicator":"Yes","beginDate":"2022-03-11","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-03-11","modifiedBy":"TAYLORT","dateModified":"2022-04-18","changeDescription":"Leidos Biospecimen Roadmap; TL.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}